Abstract
A key challenge for public health policy makers is determining when an infectious disease outbreak has finished. Following a period without cases, an estimate of the probability that no further cases will occur in future (the end-of-outbreak probability) can be used to inform whether or not to declare an outbreak over. An existing quantitative approach, based on a branching process transmission model, allows the end-of-outbreak probability to be approximated from disease incidence time series, the offspring distribution and the serial interval of the pathogen (the Nishiura method). Here, we show how the end-of-outbreak probability under the same transmission model can be calculated exactly if data describing who-infected-whom (the outbreak transmission tree) are available alongside the disease incidence time series. When such data are available, for example from contact tracing studies, our novel approach (the traced transmission method) is straightforward to use. We demonstrate this by applying the traced transmission method to data from previous outbreaks of Ebola virus disease and Nipah virus infection. For both outbreak datasets considered, we find that the traced transmission method would have determined that the outbreak was over more quickly than the Nishiura method. This highlights that consideration of contact tracing data may allow stringent control interventions to be relaxed quickly at the end of an outbreak, with only a limited risk of outbreak resurgence.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by the UKRI via grant number EP/V053507/1 (NVM and RNT) and via a Doctoral Prize (WSH, grant number EP/W524311/1).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
DATA AVAILABILITY
An interactive, web-based Shiny app was developed to conduct end-of-outbreak probability calculations using the traced transmission approach. This application and underlying R code are available at https://github.com/nabury/End_of_outbreak_app. All coding and analysis was conducted in the R programming language (version 4.0.2).